SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-004026
Filing Date
2024-05-14
Accepted
2024-05-14 16:05:25
Documents
1
Period of Report
2024-05-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 3768
  Complete submission text file 0001562180-24-004026.txt   5157
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 20 PILGRAM DRIVE WINCHESTER MA 01890
Business Address
Hadas Nicole R. (Reporting) CIK: 0001602396 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36352 | Film No.: 24944212